Next Article in Journal
Monomethylierte 3-Thiacyclopentylsulfaminsäuren und ihre Süßstoffeigenschaften
Previous Article in Journal
2-Amino-5,6-dihydro-1,4-benzochinon-Derivate
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 72
Issue 1
10.3797/scipharm.aut-04-04
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity

by
D. Sriram
*,
K. Jyothi Mallika
and
P. Yogeeswari
Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Pilani 333031, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2004, 72(1), 35-41; https://doi.org/10.3797/scipharm.aut-04-04
Submission received: 8 April 2003 / Revised: 11 November 2003 / Accepted: 11 November 2003 / Published: 9 March 2004
Versions Notes

Abstract

3-Substituted-5-(4-pyridylcarboxamide)tetrahydro-2H-[1,3,5]thiadizine-2-thione derivatives (1-9) were synthesized as derivatives of isoniazid (INH) to overcome the resistance developed with its therapeutic use. The structures were confirmed by their spectral and elemental analyses data. These derivatives revealed higher lipophilicity compared with INH. The antimycobacterial activity of the synthesized compounds and INH was evaluated in vitro against Mycobacterium tuberculosis H37Rv at 6.25 µg/ml in BACTEC 12B medium using the BACTEC 460 radiometric system. The derivatives exhibited antitubercular activity.
Keywords: Isoniazid; Antitubercular Isoniazid; Antitubercular

Share and Cite

MDPI and ACS Style

Sriram, D.; Jyothi Mallika, K.; Yogeeswari, P. Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity. Sci. Pharm. 2004, 72, 35-41. https://doi.org/10.3797/scipharm.aut-04-04

AMA Style

Sriram D, Jyothi Mallika K, Yogeeswari P. Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity. Scientia Pharmaceutica. 2004; 72(1):35-41. https://doi.org/10.3797/scipharm.aut-04-04

Chicago/Turabian Style

Sriram, D., K. Jyothi Mallika, and P. Yogeeswari. 2004. "Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity" Scientia Pharmaceutica 72, no. 1: 35-41. https://doi.org/10.3797/scipharm.aut-04-04

APA Style

Sriram, D., Jyothi Mallika, K., & Yogeeswari, P. (2004). Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity. Scientia Pharmaceutica, 72(1), 35-41. https://doi.org/10.3797/scipharm.aut-04-04

Article Metrics

Back to TopTop